Decision letter for "Monlunabant in adults with obesity and metabolic syndrome: open-label extension of a phase 2a trial"

View at publisher Summarise with VIRAT

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Pharmacology and Obesity Treatment Adipokines Inflammation and Metabolic Diseases Diabetes Treatment and Management

Publication details

Journal / source
Publons reviews and discussion
Publication date
6 February 2026
Language
EN